Health Canada Approves Novo’s Ozempic To Reduce Risk Of Kidney Function Decline, Cardiovascular Death
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1...
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1...
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between...
In the 1960s, solo practice was the norm—one dentist owned and operated their own clinic. (iStock) As the number of...
January 22, 2025 2 min read Add topic to email alerts Receive an email when...
UKB eGFR-trajectories exhibit an approximately linear decline of −1 mL/min/1.73 m2/yearWe analyzed unrelated European-ancestry UKB individuals without acute kidney injury (AKI) or...
Study design and populationThe detailed study design and methods of CHARLS have been detailed elsewhere20. In summary, CHARLS is a...